Literature DB >> 21319793

Nox5 forms a functional oligomer mediated by self-association of its dehydrogenase domain.

Tsukasa Kawahara1, Heather M Jackson, Susan M E Smith, Paul D Simpson, J David Lambeth.   

Abstract

Nox5 belongs to the calcium-regulated subfamily of NADPH oxidases (Nox). Like other calcium-regulated Noxes, Nox5 has an EF-hand-containing calcium-binding domain at its N-terminus, a transmembrane heme-containing region, and a C-terminal dehydrogenase (DH) domain that binds FAD and NADPH. While Nox1-4 require regulatory subunits, including p22phox, Nox5 activity does not depend on any subunits. We found that inactive point mutants and truncated forms of Nox5 (including the naturally expressed splice form, Nox5S) inhibit full-length Nox5, consistent with formation of a dominant negative complex. Oligomerization of full-length Nox5 was demonstrated using co-immunoprecipitation of coexpressed, differentially tagged forms of Nox5 and occurred in a manner independent of calcium ion. Several approaches were used to show that the DH domain mediates oligomerization: Nox5 could be isolated as a multimer when the calcium-binding domain and/or the N-terminal polybasic region (PBR-N) was deleted, but deletion of the DH domain eliminated oligomerization. Further, a chimera containing the transmembrane domain of Ciona intestinalis voltage sensor-containing phosphatase (CiVSP) fused to the Nox5 DH domain formed a co-immunoprecipitating complex with, and functioned as a dominant inhibitor of, full-length Nox5. Radiation inactivation of Nox5 overexpressed in HEK293 cells and endogenously expressed in human aortic smooth muscle cells indicated molecular masses of ∼350 and ∼300 kDa, respectively, consistent with a tetramer being the functionally active unit. Thus, Nox5 forms a catalytically active oligomer in the membrane that is mediated by its dehydrogenase domain. As a result of oligomerization, the short, calcium-independent splice form, Nox5S, may function as an endogenous inhibitor of calcium-stimulated ROS generation by full-length Nox5.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21319793      PMCID: PMC3073450          DOI: 10.1021/bi1020088

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  54 in total

1.  Membrane enzyme systems. Molecular size determinations by radiation inactivation.

Authors:  G R Kepner; R I Macey
Journal:  Biochim Biophys Acta       Date:  1968-09-17

2.  Radiation inactivation of membrane proteins: molecular weight estimates in situ and after Triton X-100 solubilization.

Authors:  G Beauregard; M Potier
Journal:  Anal Biochem       Date:  1984-08-01       Impact factor: 3.365

3.  Assembly and activation of the phagocyte NADPH oxidase. Specific interaction of the N-terminal Src homology 3 domain of p47phox with p22phox is required for activation of the NADPH oxidase.

Authors:  H Sumimoto; K Hata; K Mizuki; T Ito; Y Kage; Y Sakaki; Y Fukumaki; M Nakamura; K Takeshige
Journal:  J Biol Chem       Date:  1996-09-06       Impact factor: 5.157

4.  Identification of the maturation factor for dual oxidase. Evolution of an eukaryotic operon equivalent.

Authors:  Helmut Grasberger; Samuel Refetoff
Journal:  J Biol Chem       Date:  2006-05-01       Impact factor: 5.157

5.  Structure of the N-terminal regulatory domain of a plant NADPH oxidase and its functional implications.

Authors:  Takashi Oda; Hiroshi Hashimoto; Naoyuki Kuwabara; Satoko Akashi; Kokoro Hayashi; Chojiro Kojima; Hann Ling Wong; Tsutomu Kawasaki; Ko Shimamoto; Mamoru Sato; Toshiyuki Shimizu
Journal:  J Biol Chem       Date:  2009-10-28       Impact factor: 5.157

6.  A voltage-sensing phosphatase, Ci-VSP, which shares sequence identity with PTEN, dephosphorylates phosphatidylinositol 4,5-bisphosphate.

Authors:  Hirohide Iwasaki; Yoshimichi Murata; Youngjun Kim; Md Israil Hossain; Carolyn A Worby; Jack E Dixon; Thomas McCormack; Takehiko Sasaki; Yasushi Okamura
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-04       Impact factor: 11.205

7.  Nox regulation of smooth muscle contraction.

Authors:  Darren R Ritsick; William A Edens; Victoria Finnerty; J David Lambeth
Journal:  Free Radic Biol Med       Date:  2007-03-12       Impact factor: 7.376

8.  Nox5 mediates PDGF-induced proliferation in human aortic smooth muscle cells.

Authors:  Desmond B Jay; Christopher A Papaharalambus; Bonnie Seidel-Rogol; Anna E Dikalova; Bernard Lassègue; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2008-04-26       Impact factor: 7.376

9.  Molecular evolution of Phox-related regulatory subunits for NADPH oxidase enzymes.

Authors:  Tsukasa Kawahara; J David Lambeth
Journal:  BMC Evol Biol       Date:  2007-09-27       Impact factor: 3.260

10.  Molecular evolution of the reactive oxygen-generating NADPH oxidase (Nox/Duox) family of enzymes.

Authors:  Tsukasa Kawahara; Mark T Quinn; J David Lambeth
Journal:  BMC Evol Biol       Date:  2007-07-06       Impact factor: 3.260

View more
  21 in total

1.  Ebselen and congeners inhibit NADPH oxidase 2-dependent superoxide generation by interrupting the binding of regulatory subunits.

Authors:  Susan M E Smith; Jaeki Min; Thota Ganesh; Becky Diebold; Tsukasa Kawahara; Yerun Zhu; James McCoy; Aiming Sun; James P Snyder; Haian Fu; Yuhong Du; Iestyn Lewis; J David Lambeth
Journal:  Chem Biol       Date:  2012-06-22

Review 2.  Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.

Authors:  Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Circ Res       Date:  2012-05-11       Impact factor: 17.367

3.  Expression and functional significance of NADPH oxidase 5 (Nox5) and its splice variants in human blood vessels.

Authors:  Deepesh Pandey; Anand Patel; Vijay Patel; Feng Chen; Jin Qian; Yusi Wang; Scott A Barman; Richard C Venema; David W Stepp; R Daniel Rudic; David J R Fulton
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

Review 4.  Enzymatic regulation and functional relevance of NOX5.

Authors:  Feng Chen; Yusi Wang; Scott Barman; David J R Fulton
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 5.  P21-activated kinase in inflammatory and cardiovascular disease.

Authors:  Domenico M Taglieri; Masuko Ushio-Fukai; Michelle M Monasky
Journal:  Cell Signal       Date:  2014-05-02       Impact factor: 4.315

Review 6.  NADPH oxidases as therapeutic targets in ischemic stroke.

Authors:  Timo Kahles; Ralf P Brandes
Journal:  Cell Mol Life Sci       Date:  2012-05-23       Impact factor: 9.261

Review 7.  Nox NADPH oxidases and the endoplasmic reticulum.

Authors:  Francisco R M Laurindo; Thaís L S Araujo; Thalita B Abrahão
Journal:  Antioxid Redox Signal       Date:  2014-02-26       Impact factor: 8.401

Review 8.  NADPH oxidases-do they play a role in TRPC regulation under hypoxia?

Authors:  Monika Malczyk; Christine Veith; Ralph T Schermuly; Thomas Gudermann; Alexander Dietrich; Natascha Sommer; Norbert Weissmann; Oleg Pak
Journal:  Pflugers Arch       Date:  2015-10-01       Impact factor: 3.657

9.  Characterization of NADPH oxidase 5 expression in human tumors and tumor cell lines with a novel mouse monoclonal antibody.

Authors:  Smitha Antony; Yongzhong Wu; Stephen M Hewitt; Miriam R Anver; Donna Butcher; Guojian Jiang; Jennifer L Meitzler; Han Liu; Agnes Juhasz; Jiamo Lu; Krishnendu K Roy; James H Doroshow
Journal:  Free Radic Biol Med       Date:  2013-07-11       Impact factor: 7.376

Review 10.  Nox family NADPH oxidases in mechano-transduction: mechanisms and consequences.

Authors:  Ralf P Brandes; Norbert Weissmann; Katrin Schröder
Journal:  Antioxid Redox Signal       Date:  2013-07-05       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.